<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-01-24" modified="2017-11-22" version="120">
<accession>Q3LXA3</accession>
<accession>Q2L9C1</accession>
<accession>Q53EQ9</accession>
<accession>Q9BVA7</accession>
<accession>Q9H895</accession>
<name>TKFC_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="16">Triokinase/FMN cyclase</fullName>
</recommendedName>
<alternativeName>
<fullName>Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)</fullName>
</alternativeName>
<domain>
<recommendedName>
<fullName>ATP-dependent dihydroxyacetone kinase</fullName>
<shortName>DHA kinase</shortName>
<ecNumber>2.7.1.28</ecNumber>
<ecNumber>2.7.1.29</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Glycerone kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Triokinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Triose kinase</fullName>
</alternativeName>
</domain>
<domain>
<recommendedName>
<fullName>FAD-AMP lyase (cyclizing)</fullName>
<ecNumber>4.6.1.15</ecNumber>
</recommendedName>
<alternativeName>
<fullName>FAD-AMP lyase (cyclic FMN forming)</fullName>
</alternativeName>
<alternativeName>
<fullName>FMN cyclase</fullName>
</alternativeName>
</domain>
</protein>
<gene>
<name type="primary" evidence="16">TKFC</name>
<name type="synonym" evidence="16">DAK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="338" first="1682" last="1689">
<title>Identification of human and rat FAD-AMP lyase (cyclic FMN forming) as ATP-dependent dihydroxyacetone kinases.</title>
<authorList>
<person name="Cabezas A."/>
<person name="Costas M.J."/>
<person name="Pinto R.M."/>
<person name="Couto A."/>
<person name="Cameselle J.C."/>
</authorList>
<dbReference type="PubMed" id="16289032"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.10.142"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>FAD-AMP LYASE ACTIVITY</scope>
<scope>VARIANT THR-185</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<title>Human brain Dha kinase/FMN cyclase splice variant mRNA encoding a shorter protein inactive as Dha kinase and FMN cyclase.</title>
<authorList>
<person name="Cabezas A."/>
<person name="Costas M.J."/>
<person name="Pinto R.M."/>
<person name="Couto A."/>
<person name="Cameselle J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT THR-185</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT THR-185</scope>
<source>
<tissue>Thyroid</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT THR-185</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Cervix</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1973" name="Blood" volume="41" first="559" last="568">
<title>Dihydroxyacetone metabolism by human erythrocytes: demonstration of triokinase activity and its characterization.</title>
<authorList>
<person name="Beutler E."/>
<person name="Guinto E."/>
</authorList>
<dbReference type="PubMed" id="4688871"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>IDENTITY OF TRIOKINASE AND DIHYDROXYACETONE KINASE</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="11706" last="11711">
<title>Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.</title>
<authorList>
<person name="Diao F."/>
<person name="Li S."/>
<person name="Tian Y."/>
<person name="Zhang M."/>
<person name="Xu L.G."/>
<person name="Zhang Y."/>
<person name="Wang R.P."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Zhong B."/>
<person name="Tien P."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17600090"/>
<dbReference type="DOI" id="10.1073/pnas.0700544104"/>
</citation>
<scope>INTERACTION WITH IFIH1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="10620" last="10636">
<title>Bifunctional homodimeric triokinase/FMN cyclase: contribution of protein domains to the activities of the human enzyme and molecular dynamics simulation of domain movements.</title>
<authorList>
<person name="Rodrigues J.R."/>
<person name="Couto A."/>
<person name="Cabezas A."/>
<person name="Pinto R.M."/>
<person name="Ribeiro J.M."/>
<person name="Canales J."/>
<person name="Costas M.J."/>
<person name="Cameselle J.C."/>
</authorList>
<dbReference type="PubMed" id="24569995"/>
<dbReference type="DOI" id="10.1074/jbc.M113.525626"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF THR-112; LYS-204; HIS-221; ASP-401; ASP-403; CYS-404; SER-446 AND ASP-556</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350 AND SER-511</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="3 4 8 9 11">Catalyzes both the phosphorylation of dihydroxyacetone and of glyceraldehyde, and the splitting of ribonucleoside diphosphate-X compounds among which FAD is the best substrate. Represses IFIH1-mediated cellular antiviral response (PubMed:17600090).</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">ATP + glycerone = ADP + glycerone phosphate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">ATP + D-glyceraldehyde = ADP + D-glyceraldehyde 3-phosphate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">FAD = AMP + riboflavin cyclic-4',5'-phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="2">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="cofactor">
<cofactor evidence="2">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
<cofactor evidence="2">
<name>Co(2+)</name>
<dbReference type="ChEBI" id="CHEBI:48828"/>
</cofactor>
<text evidence="2">Manganese or cobalt are requested for FAD-AMP lyase activity.</text>
</comment>
<comment type="enzyme regulation">
<text>Each activity is inhibited by the substrate(s) of the other.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="11">0.5 uM for dihydroxyacetone</KM>
<KM evidence="11">11 uM for glyceraldehyde</KM>
<KM evidence="10">1.55 uM for dihydroxyacetone</KM>
<KM evidence="10">43.2 uM for ATP</KM>
<KM evidence="10">18.1 uM for glyceraldehyde</KM>
<KM evidence="10">7 uM for FAD</KM>
<KM evidence="10">12 uM for ADP-glucose</KM>
<KM evidence="10">317 uM for UDP-glucose</KM>
<KM evidence="10">263 uM for UDP-galactose</KM>
</kinetics>
<phDependence>
<text evidence="11">Optimum pH is 6.6.</text>
</phDependence>
</comment>
<comment type="subunit">
<text evidence="3 9">Homodimer (By similarity). Interacts with IFIH1 (via the CARD domains), the interaction is inhibited by viral infection (PubMed:17600090).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4291069"/>
<interactant intactId="EBI-6115771">
<id>Q9BYX4</id>
<label>IFIH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4291069"/>
<interactant intactId="EBI-727004">
<id>O00560</id>
<label>SDCBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q3LXA3-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q3LXA3-2</id>
<name>2</name>
<sequence type="described" ref="VSP_057181"/>
<text>Inactive as DHA kinase and FMN cyclase.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="11">Detected in erythrocytes (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="10">DhaK and DhaL domains have differential roles, individually DhaK is inactive and DhaL displays cyclase but not kinase activity.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the dihydroxyacetone kinase (DAK) family.</text>
</comment>
<dbReference type="EC" id="2.7.1.28"/>
<dbReference type="EC" id="2.7.1.29"/>
<dbReference type="EC" id="4.6.1.15"/>
<dbReference type="EMBL" id="DQ138290">
<property type="protein sequence ID" value="ABA10576.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ344550">
<property type="protein sequence ID" value="ABC70184.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023915">
<property type="protein sequence ID" value="BAB14722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223580">
<property type="protein sequence ID" value="BAD97300.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP003108">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001341">
<property type="protein sequence ID" value="AAH01341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8003.1">
<molecule id="Q3LXA3-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_056348.2">
<molecule id="Q3LXA3-1"/>
<property type="nucleotide sequence ID" value="NM_015533.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016873010.1">
<property type="nucleotide sequence ID" value="XM_017017521.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016873012.1">
<property type="nucleotide sequence ID" value="XM_017017523.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.6278"/>
<dbReference type="ProteinModelPortal" id="Q3LXA3"/>
<dbReference type="SMR" id="Q3LXA3"/>
<dbReference type="BioGrid" id="117481">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="DIP" id="DIP-60967N"/>
<dbReference type="IntAct" id="Q3LXA3">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="MINT" id="MINT-5001370"/>
<dbReference type="STRING" id="9606.ENSP00000378360"/>
<dbReference type="iPTMnet" id="Q3LXA3"/>
<dbReference type="PhosphoSitePlus" id="Q3LXA3"/>
<dbReference type="BioMuta" id="DAK"/>
<dbReference type="DMDM" id="311033370"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00551024"/>
<dbReference type="EPD" id="Q3LXA3"/>
<dbReference type="MaxQB" id="Q3LXA3"/>
<dbReference type="PaxDb" id="Q3LXA3"/>
<dbReference type="PeptideAtlas" id="Q3LXA3"/>
<dbReference type="PRIDE" id="Q3LXA3"/>
<dbReference type="DNASU" id="26007"/>
<dbReference type="Ensembl" id="ENST00000394900">
<molecule id="Q3LXA3-1"/>
<property type="protein sequence ID" value="ENSP00000378360"/>
<property type="gene ID" value="ENSG00000149476"/>
</dbReference>
<dbReference type="GeneID" id="26007"/>
<dbReference type="KEGG" id="hsa:26007"/>
<dbReference type="UCSC" id="uc001nre.4">
<molecule id="Q3LXA3-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="26007"/>
<dbReference type="DisGeNET" id="26007"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000149476.14"/>
<dbReference type="GeneCards" id="TKFC"/>
<dbReference type="HGNC" id="HGNC:24552">
<property type="gene designation" value="TKFC"/>
</dbReference>
<dbReference type="HPA" id="HPA039486"/>
<dbReference type="HPA" id="HPA048186"/>
<dbReference type="MIM" id="615844">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q3LXA3"/>
<dbReference type="OpenTargets" id="ENSG00000149476"/>
<dbReference type="PharmGKB" id="PA142672014"/>
<dbReference type="eggNOG" id="KOG2426">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2376">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000015415"/>
<dbReference type="HOGENOM" id="HOG000234158"/>
<dbReference type="HOVERGEN" id="HBG079502"/>
<dbReference type="InParanoid" id="Q3LXA3"/>
<dbReference type="KO" id="K00863"/>
<dbReference type="OMA" id="AWPNVAK"/>
<dbReference type="PhylomeDB" id="Q3LXA3"/>
<dbReference type="TreeFam" id="TF313821"/>
<dbReference type="BRENDA" id="2.7.1.29">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="4.6.1.15">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168928">
<property type="pathway name" value="DDX58/IFIH1-mediated induction of interferon-alpha/beta"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-70350">
<property type="pathway name" value="Fructose catabolism"/>
</dbReference>
<dbReference type="ChiTaRS" id="DAK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="DAK_(gene)"/>
<dbReference type="GenomeRNAi" id="26007"/>
<dbReference type="PMAP-CutDB" id="Q3LXA3"/>
<dbReference type="PRO" id="PR:Q3LXA3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000149476"/>
<dbReference type="CleanEx" id="HS_DAK"/>
<dbReference type="ExpressionAtlas" id="Q3LXA3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q3LXA3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0034012">
<property type="term" value="F:FAD-AMP lyase (cyclizing) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004371">
<property type="term" value="F:glycerone kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050354">
<property type="term" value="F:triokinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046835">
<property type="term" value="P:carbohydrate phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044262">
<property type="term" value="P:cellular carbohydrate metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061624">
<property type="term" value="P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006071">
<property type="term" value="P:glycerol metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0039534">
<property type="term" value="P:negative regulation of MDA-5 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045088">
<property type="term" value="P:regulation of innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR012734">
<property type="entry name" value="DhaK_ATP"/>
</dbReference>
<dbReference type="InterPro" id="IPR004006">
<property type="entry name" value="DhaK_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004007">
<property type="entry name" value="DhaL_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036117">
<property type="entry name" value="DhaL_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF02733">
<property type="entry name" value="Dak1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02734">
<property type="entry name" value="Dak2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01120">
<property type="entry name" value="Dak2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF101473">
<property type="entry name" value="SSF101473"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR02361">
<property type="entry name" value="dak_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51481">
<property type="entry name" value="DHAK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51480">
<property type="entry name" value="DHAL"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0170">Cobalt</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0274">FAD</keyword>
<keyword id="KW-0285">Flavoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0511">Multifunctional enzyme</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Triokinase/FMN cyclase" id="PRO_0000121525">
<location>
<begin position="1"/>
<end position="575"/>
</location>
</feature>
<feature type="domain" description="DhaK" evidence="6">
<location>
<begin position="9"/>
<end position="336"/>
</location>
</feature>
<feature type="domain" description="DhaL" evidence="5">
<location>
<begin position="372"/>
<end position="571"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2">
<location>
<begin position="401"/>
<end position="404"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2">
<location>
<begin position="446"/>
<end position="447"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2">
<location>
<begin position="494"/>
<end position="495"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2">
<location>
<begin position="556"/>
<end position="558"/>
</location>
</feature>
<feature type="region of interest" description="Dihydroxyacetone binding" evidence="2">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="active site" description="Tele-hemiaminal-histidine intermediate" evidence="6">
<location>
<position position="221"/>
</location>
</feature>
<feature type="binding site" description="Dihydroxyacetone" evidence="6">
<location>
<position position="109"/>
</location>
</feature>
<feature type="binding site" description="Dihydroxyacetone" evidence="6">
<location>
<position position="114"/>
</location>
</feature>
<feature type="binding site" description="ATP; via carbonyl oxygen" evidence="2">
<location>
<position position="486"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="511"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="545"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057181" evidence="14">
<original>SAEAAAEATKNMEAGAGRASYISSARLEQPDPGAVAAAAILRAILEVLQS</original>
<variation>EGGGLVICP</variation>
<location>
<begin position="526"/>
<end position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2260655." id="VAR_028108" evidence="7 8 12 13">
<original>A</original>
<variation>T</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35723406." id="VAR_054780">
<original>A</original>
<variation>G</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Highly decreases kinase activity. No effect on FMN cyclase activity." evidence="10">
<original>T</original>
<variation>A</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly decreases kinase activity. No effect on FMN cyclase activity." evidence="10">
<original>K</original>
<variation>A</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity but not FMN cyclase activity." evidence="10">
<original>H</original>
<variation>A</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both kinase and FMN cyclase activities." evidence="10">
<original>D</original>
<variation>A</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both kinase and FMN cyclase activities." evidence="10">
<original>D</original>
<variation>A</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases both kinase and FMN cyclase activities." evidence="10">
<original>C</original>
<variation>A</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases both kinase and FMN cyclase activities." evidence="10">
<original>S</original>
<variation>A</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both kinase and FMN cyclase activities." evidence="10">
<original>D</original>
<variation>A</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB14722." ref="3" evidence="15">
<original>V</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAD97300." ref="4" evidence="15">
<original>A</original>
<variation>S</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB14722." ref="3" evidence="15">
<original>V</original>
<variation>A</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB14722." ref="3" evidence="15">
<original>L</original>
<variation>P</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB14722." ref="3" evidence="15">
<original>D</original>
<variation>G</variation>
<location>
<position position="497"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="F1RKQ4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q4KLZ6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00813"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00814"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16289032"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17600090"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24569995"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="4688871"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="13" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="14" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<evidence key="16" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:24552"/>
</source>
</evidence>
<sequence length="575" mass="58947" checksum="4DB8C5326F65122C" modified="2010-11-02" version="2">
MTSKKLVNSVAGCADDALAGLVACNPNLQLLQGHRVALRSDLDSLKGRVALLSGGGSGHE
PAHAGFIGKGMLTGVIAGAVFTSPAVGSILAAIRAVAQAGTVGTLLIVKNYTGDRLNFGL
AREQARAEGIPVEMVVIGDDSAFTVLKKAGRRGLCGTVLIHKVAGALAEAGVGLEEIAKQ
VNVVAKAMGTLGVSLSSCSVPGSKPTFELSADEVELGLGIHGEAGVRRIKMATADEIVKL
MLDHMTNTTNASHVPVQPGSSVVMMVNNLGGLSFLELGIIADATVRSLEGRGVKIARALV
GTFMSALEMPGISLTLLLVDEPLLKLIDAETTAAAWPNVAAVSITGRKRSRVAPAEPQEA
PDSTAAGGSASKRMALVLERVCSTLLGLEEHLNALDRAAGDGDCGTTHSRAARAIQEWLK
EGPPPASPAQLLSKLSVLLLEKMGGSSGALYGLFLTAAAQPLKAKTSLPAWSAAMDAGLE
AMQKYGKAAPGDRTMLDSLWAAGQELQAWKSPGADLLQVLTKAVKSAEAAAEATKNMEAG
AGRASYISSARLEQPDPGAVAAAAILRAILEVLQS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>